Literature DB >> 21956167

Targeting therapeutic effects: subcellular location matters. Focus on "Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology".

Judy Creighton.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21956167      PMCID： PMC3233800          DOI： 10.1152/ajpcell.00358.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  21 in total

1.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization.

Authors:  S M Warden; C Richardson; J O'Donnell; D Stapleton; B E Kemp; L A Witters
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae.

Authors:  P A Insel; B P Head; H H Patel; D M Roth; R A Bundey; J S Swaney
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

Review 3.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology.

Authors:  Mohamed Kodiha; Dennis Ho-Wo-Cheong; Ursula Stochaj
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-14       Impact factor: 4.249

5.  Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system.

Authors:  A M Turnley; D Stapleton; R J Mann; L A Witters; B E Kemp; P F Bartlett
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

6.  Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1.

Authors:  Ji-Wu Wang; Yuzuru Imai; Bingwei Lu
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 7.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Authors:  B Viollet; R Mounier; J Leclerc; A Yazigi; M Foretz; F Andreelli
Journal:  Diabetes Metab       Date:  2007-11-07       Impact factor: 6.041

Review 8.  Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.

Authors:  D Grahame Hardie
Journal:  FEBS Lett       Date:  2007-11-20       Impact factor: 4.124

9.  Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK-->ERK1/2 pathway.

Authors:  Mohamed Kodiha; James G Rassi; Claire M Brown; Ursula Stochaj
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-29       Impact factor: 4.249

10.  Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase.

Authors:  Atsushi Suzuki; Shiki Okamoto; Suni Lee; Kumiko Saito; Tetsuya Shiuchi; Yasuhiko Minokoshi
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272
View more
  3 in total

1.  Factors controlling vascular permeability: transmitting mechanical signals. Focus on "Mechanical induction of group V phospholipase A₂ causes lung inflammation and acute lung injury".

Authors:  Judy Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

2.  Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury.

Authors:  Ming-Yuan Jian; Mikhail F Alexeyev; Paul E Wolkowicz; Jaroslaw W Zmijewski; Judy R Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

3.  N-cadherin coordinates AMP kinase-mediated lung vascular repair.

Authors:  Ming-Yuan Jian; Yanping Liu; Qian Li; Paul Wolkowicz; Mikhail Alexeyev; Jaroslaw Zmijewski; Judy Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-06       Impact factor: 5.464
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.